🔎 Trials Near Me

መነሻ › Small Cell የሳንባ ካንሰር › Tennessee › Nashville

በNashville፣ TN ለSmall Cell የሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለSmall Cell የሳንባ ካንሰር የሚደረጉ 20 ጥናቶች በNashville እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT03460977

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI), Nashville
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06586957

DESTINY-PANTUMOUR04

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Research Site, Nashville
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07124000

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06047379

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI Oncology Partners /ID# 279779, Nashville
  • Vanderbilt University Medical Center /ID# 280169, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07365241

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon - Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05983432

A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07325136

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI OP (Oncology Partners), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT07218146

A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06646276

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute ( Site 7001), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06780137

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦገስ 2026 · NCT06726148

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07488923

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT06095505

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT05592626

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Tennessee Oncology, PLLC, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2026 · NCT06931626

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁላይ 2026 · NCT06131840

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute - Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁላይ 2026 · NCT07174583

A Study of LY4175408 in Participants With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT07046923

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site 136, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኖቬም 2025 · NCT05914116

በሌሎች ከተሞች ለSmall Cell የሳንባ ካንሰር የሚደረጉ ጥናቶች

በNashville ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።